UnitedHealth shares gain on Bank of America upgrade as earnings outlook improves

Traders Union
All News
Financial News
UnitedHealth shares gain on BofA upgrade

All news

Editors' Picks

Crypto News

Financial News

Market Voices

Billionaires

Companies

Broker News

Regulators News

Ciaran Ryan

2 hours ago

UnitedHealth shares gain on Bank of America upgrade as earnings outlook improves — UnitedHealth stock upgraded

UnitedHealth is advancing a multiyear effort to lift margins through cost cuts, business simplification and targeted investment across its healthcare operations. That strategy is now supporting a stronger earnings outlook, with Bank of America seeing further upside for the stock as operational changes take hold.

Highlights

Bank of America upgrades UnitedHealth to buy from neutral, raises price target to $450 from $420, implying 19% upside, as shares gain 3% premarket.
UnitedHealth’s earnings power is now about 50% above its prior 2026 outlook, with potential for earnings per share to exceed $26 by 2028, 5%–10% above consensus.
UnitedHealth’s 26% share rise over the past year reflects a margin-focused strategy, including Optum UK divestiture and AI investment, supporting 13%–16% EPS growth projections.

Broker upgrade highlights stronger earnings path

As reported by Bank of America, according to CNBC, the bank upgrades UnitedHealth to buy from neutral and raises its price target to $450 from $420, implying 19% upside from Wednesday’s close. UnitedHealth shares are up 3% in premarket trading.

Analyst Kevin Fischbeck says incoming data points make it harder to argue that the company’s strong first quarter is only the result of weaker flu trends and storms. He says the bank maintains a more bullish near-term view because of the earnings power UnitedHealth has relative to its 2026 guidance.

Bank of America says UnitedHealth’s earnings power now stands about 50% above its previously stated outlook for 2026. The company forecasts it can reach the low end of its target margins across all businesses by 2028, a level that the analyst says could put earnings per share above $26, or 5% to 10% above the Street consensus estimate.

Strategy shift supports margin recovery

Over the past year, UnitedHealth shares have risen nearly 26% as the company executes a broad strategy aimed at improving margins. The plan includes shrinking membership, selling the UK arm of its tech-driven Optum healthcare delivery unit and investing in artificial intelligence, among other steps.

Bank of America points to Optum Health as one potential catalyst for further bottom-line growth as the business deepens its push to acquire physician groups and clinics. Fischbeck says that once subsegment margin targets are reached, UnitedHealth is likely to remain positioned to grow earnings per share by at least 13% to 16% for the next few years, helped by additional room for Optum Health margin improvement and a later pivot back to membership growth in other businesses.

The positive call broadly aligns with wider Wall Street sentiment. Of the 30 analysts covering UnitedHealth, 23 rate the stock buy or strong buy, according to LSEG data.

Our earlier article on Mitie’s growth plan and CEO succession outlined how the company is setting up its next expansion phase after posting double-digit gains in annual revenue and adjusted operating profit. We noted that contract wins, integration synergies and ongoing investment in AI are central to Mitie’s push toward its FY25–27 margin targets as leadership transition plans progress.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.